Why Are Kids In Asthma Hotspots In NYC More Likely To Visit The ER? Exercise May Be A Factor

Asthmatic children in New York City neighborhoods with high rates of asthma make many more visits to the emergency room (ER) than those who live in other parts of the city. While socioeconomic factors such as lack of adequate preventive care are part of the equation (high-asthma neighborhoods tend to be lower income), new research points to a possible biological basis for the disparity...

An Inflammatory Protein Plays An Unexpected Role In Lung Infections

The immune system responds to infections in the lungs by recruiting neutrophils, a group of immune cells that are responsible for recognizing and eliminating pathogens, to the site of infection. In addition to killing infectious pathogens, neutrophils also drive inflammation, which can lead to poor lung function and sometimes fatal complications...

High Vitamin D Doses Reduce Respiratory Tract Infection Risk

Patients who are prone to infections and are given high vitamin D doses for one year have a significantly lower risk of developing respiratory tract infection, compared to their counterparts who do not receive the extra daily vitamin, researchers from the Karolinska Institute and Karolinska University Hospital reported this month in BMJ Open...

Sleep-Disordered Breathing A Problem For 1 In 10 Children Aged 6 To 8 Years

Approximately ten per cent of 6 year olds have sleep-disordered breathing, according to a recent Finnish study. The risk is increased among children with enlarged tonsils, crossbite and convex facial profile. Unlike in adults, excess body fat is not associated with sleep-disordered breathing in this age group...

Antibiotic No Better For Coughs, Uncomplicated Chest Infections Than No Medication

Amoxicillin, the antibiotic doctors often prescribe for persistent coughs caused by uncomplicated chest infections such as bronchitis, is no more effective at easing symptoms than no medication at all, even in older patients. This was the finding of the largest randomised placebo controlled trial of antibiotics for lower respiratory tract infections (LRTI) done to date...

Press Release

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that Merck/Kyorin’s Singulair is a dominant player among maintenance therapies in the asthma market, attaining sales of nearly $3.2 billion and the second-highest patient share in the major markets in 2011. However, generic versions of Singulair launched in the United States ...